Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Cunningham

Showing results (901-910 of 980) with videos related to

Pageof 98
Sort By:
Life Sciences|December 29, 2004
The cholinesterase inhibitor, phenserine, improves Morris water maze performance of scopolamine-treated ratsAnne M Janas, Steven C Cunningham, Kara B Duffy, et al.
Techniques in Coloproctology|May 22, 2023
Comparison of proactive and conventional treatment of anastomotic leakage in rectal cancer surgery: a multicentre retrospective cohort seriesK Talboom, N G Greijdanus, N Brinkman, et al.
Hepatology (Baltimore, Md.)|May 27, 2015
Modeling correction of severe urea cycle defects in the growing murine liver using a hybrid recombinant adeno-associated virus/piggyBac transposase gene delivery systemSharon C Cunningham, Susan M Siew, Claus V Hallwirth, et al.
Genomics|May 16, 2001
Genomic organization of the CC chemokine mip-3alpha/CCL20/larc/exodus/SCYA20, showing gene structure, splice variants, and chromosome localizationR T Nelson, J Boyd, R P Gladue, et al.
British Journal of Cancer|June 11, 1999
Magnetic resonance detects metabolic changes associated with chemotherapy-induced apoptosisS M Ronen, F DiStefano, C L McCoy, et al.
Blood|August 1, 1996
Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation StudyM E Hill, K A MacLennan, D C Cunningham, et al.
Breast Cancer Research and Treatment|February 13, 2017
The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancerJ S Thomas, A M Hanby, N Russell, et al.
Journal of Pediatric Hematology/Oncology|September 19, 2008
Hypocalcemia in a patient with osteosarcoma and 22q11.2 deletion syndromeFrancis J Mussai, Lea C Cunningham, Geoffrey Rezvani, et al.
The Oncologist|February 12, 2020
FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host DiseaseDonna Przepiorka, Lola Luo, Sriram Subramaniam, et al.
JMIR Formative Research|December 12, 2024
Exploring Self-Reported Symptoms for Developing and Evaluating Digital Symptom Checkers for Polycystic Ovarian Syndrome, Endometriosis, and Uterine Fibroids: Exploratory Survey StudyAidan P Wickham, Yella Hewings-Martin, Frederick Gb Goddard, et al.
Pageof 98

Showing results (901-910 of 980) with videos related to

Sort By:
Pageof 98
Life Sciences|December 29, 2004
The cholinesterase inhibitor, phenserine, improves Morris water maze performance of scopolamine-treated ratsAnne M Janas, Steven C Cunningham, Kara B Duffy, et al.
Techniques in Coloproctology|May 22, 2023
Comparison of proactive and conventional treatment of anastomotic leakage in rectal cancer surgery: a multicentre retrospective cohort seriesK Talboom, N G Greijdanus, N Brinkman, et al.
Hepatology (Baltimore, Md.)|May 27, 2015
Modeling correction of severe urea cycle defects in the growing murine liver using a hybrid recombinant adeno-associated virus/piggyBac transposase gene delivery systemSharon C Cunningham, Susan M Siew, Claus V Hallwirth, et al.
Genomics|May 16, 2001
Genomic organization of the CC chemokine mip-3alpha/CCL20/larc/exodus/SCYA20, showing gene structure, splice variants, and chromosome localizationR T Nelson, J Boyd, R P Gladue, et al.
British Journal of Cancer|June 11, 1999
Magnetic resonance detects metabolic changes associated with chemotherapy-induced apoptosisS M Ronen, F DiStefano, C L McCoy, et al.
Blood|August 1, 1996
Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation StudyM E Hill, K A MacLennan, D C Cunningham, et al.
Breast Cancer Research and Treatment|February 13, 2017
The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancerJ S Thomas, A M Hanby, N Russell, et al.
Journal of Pediatric Hematology/Oncology|September 19, 2008
Hypocalcemia in a patient with osteosarcoma and 22q11.2 deletion syndromeFrancis J Mussai, Lea C Cunningham, Geoffrey Rezvani, et al.
The Oncologist|February 12, 2020
FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host DiseaseDonna Przepiorka, Lola Luo, Sriram Subramaniam, et al.
JMIR Formative Research|December 12, 2024
Exploring Self-Reported Symptoms for Developing and Evaluating Digital Symptom Checkers for Polycystic Ovarian Syndrome, Endometriosis, and Uterine Fibroids: Exploratory Survey StudyAidan P Wickham, Yella Hewings-Martin, Frederick Gb Goddard, et al.
Pageof 98